EU pumps €330M into nuclear innovation to secure energy future
The European Union has unveiled a €330 million funding package to boost nuclear energy innovation. The 2026-2027 Euratom Research and Training Work Programme targets both fission and fusion technologies, aiming to strengthen Europe's energy security and reduce emissions. A key goal is bridging the gap between scientific research and real-world industrial use.
A major portion of the budget—€222 million—will go toward fusion energy research. The funds aim to speed up development, bringing the technology closer to commercial use. Early-stage fusion companies will receive support to scale up their work and attract private investors.
The programme also allocates €108 million for nuclear fission projects. This includes next-generation reactors, advanced waste management, and innovations in materials and fuels to extend reactor lifespans. Another focus is improving efficiency in existing nuclear plants. Workforce training is a priority, with initiatives to tackle skill shortages in the nuclear sector. Grants and research opportunities will help build expertise in fusion-related fields. The scheme also ensures access to critical research infrastructure for scientists and engineers. Beyond energy, the programme funds nuclear applications in healthcare. This includes securing supplies of medical isotopes and developing new treatments. A European public-private partnership will help turn research breakthroughs into practical solutions. The plan aligns with a future EU fusion strategy, reinforcing ITER as the centrepiece for accelerating fusion commercialisation. While details on cross-border collaboration remain unclear, the funding signals a push toward energy independence and decarbonisation.
The €330 million investment will support fusion and fission research, workforce training, and healthcare applications. The programme seeks to advance nuclear technology while reducing Europe's reliance on external energy sources. Funding will also help transition scientific progress into industrial and medical use.
